Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression
Phyllis Kanki(Harvard University), Souleymane Mboup(Institute of Health Research, Epidemiological Surveillance and Training)
Cited by 381
Related Papers
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
|The Lancet Global Health|2016|182
Dating the common ancestor of SIVcpz and HIV‐1 group M and the origin of HIV‐1 subtypes by using a new method to uncover clock‐like molecular evolution
|The FASEB Journal|2000|172
HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme
|JHEP Reports|2022|22